The Procter & Gamble Company
NYSE-PG
Company Overview
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Name
The Procter & Gamble Company
CEO
Jon R. Moeller
Website
www.pginvestor.com
Sector
Household Products
Year Founded
1837
Company Statistics
Profile
Market Cap
—
EV
—
Shares Out
—
Revenue
—
Employees
—
Margins
Gross
—
EBITDA
—
Operating
—
Pre-Tax
—
Net
—
FCF
—
Returns (5Yr Avg)
ROA
—
ROTA
—
ROE
—
ROCE
—
ROIC
—
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
—
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
—
Net Debt
—
Debt/Equity
—
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
—
Rev 5Yr
—
Rev 10Yr
—
Dil EPS 3Yr
—
Dil EPS 5Yr
—
Dil EPS 10Yr
—
Rev Fwd 2Yr
—
EBITDA Fwd 2Yr
—
EPS Fwd 2Yr
—
EPS LT Growth Est
—
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—
Bulls Say
If retailers and consumers continue to favor leading branded operators, given their efficiacy halo, P&G's sales trajectory may outpace our expectations.
Opportunities to further narrow its product mix could enable P&G to more effectively direct brand spending to the highest-return aisles.
Despite completing two $10 billion cost-reduction efforts, additional savings (likely stemming from reduced overhead and higher returns on its manufacturing footprint and marketing investments) could materialize if efficiency is as ingrained in its culture as management suggests.
Bears Say
A weak consumer spending backdrop in China has been an Achilles' heel for P&G's beauty segment (nearly one fifth of sales), and demand could remain tepid until economic conditions in the region show consistent improvement.
In fiscal 2026, P&G expects around $400 million in additional costs from tariffs (about 1% of cost of goods sold, assuming no change in levies), which may dent profits if it's unable to extract inefficiencies and/or raise prices.
Foreign-exchange volatility may hamper profits at times, as a portion of P&G's products are sold in different geographic regions.
What's happening
Nov 6, 2025 - Dec 6, 2025
Procter & Gamble Faces Significant Challenges Amid Market Volatility
- Procter & Gamble Co. reached a 23-month low, closing at $144.08 on December 2, reflecting nearly a 20% decline over the past year.
- CFO Andre Schulten cited lower U.S. sales expectations and competitive pressures as key challenges during the Morgan Stanley Global Consumer & Retail Conference.
- Despite some positive product launches, investor confidence remains shaken due to downward revisions in earnings estimates and increased competition.
Over the past month, Procter & Gamble Co. has experienced a notable decline in its stock performance with an overall movement of -1.7%. This downturn is significant when compared to the S&P 500's return of 1.2%, indicating that PG underperformed by 2.8% relative to this broader market index. The company's struggles have been underscored by bearish events and shifts in sentiment that have contributed to its declining valuation.
On December 4, PG traded at $145.31 after experiencing another decline of approximately 1%. Although the company maintains a price-to-earnings (P/E) ratio that outperforms industry averages—suggesting some level of perceived value—it faces scrutiny regarding potential overvaluation amid challenging conditions related to both sales growth and market dynamics.
Despite moments of positive news such as product launches from brands like Pantene and Cascade’s partnership with Feeding America, these developments were overshadowed by pressing concerns about revised earnings estimates and increasing competition within the sector following Kimberly-Clark's acquisition moves.
Overall, Procter & Gamble Co underperformed not only against general market trends but also against its own sector benchmarks; it lagged behind the Consumer Staples (XLP) sector by -5%. As investors navigate through these turbulent waters marked by declining sales forecasts and heightened competition for consumer attention, PG remains under pressure amidst an increasingly volatile economic backdrop.